SNSF Investigator Initiated Clinical Trials (IICT) 2023

Servizio ricerca e trasferimento del sapere

Submission deadline: 26 Giugno 2023

Submission deadline: 26 May, 2023

The programme for Investigator Initiated Clinical Trials (IICTs) of the Swiss National Science Foundation (SNSF) offers targeted support for clinical studies that are of value to the patients and address important unmet medical and societal needs. 

Deadlines

The deadlines for the call 2023 are:

  • Submission of letters of intent via mySNF by 26 May 2023, 5 p.m. Swiss local time
  • If applicable, submission of PPI Preparatory Grant applications via mySNF by 26 May 2023, 5 p.m. Swiss local time
  • Submission of full proposals via mySNF by 1 November 2023, 5 p.m. Swiss local time.

Funding and duration

The funding period is limited to 60 months, including a potential preparation phase of max. 12 months.

Eligibility

All costs mentioned in the General Implementation Regulations (Clause 2 Eligible costs) and in Art. 8 of the Project Funding Regulations may be charged to the IICT grant.
They include:

  • the salaries of scientific and technical staff;
  • material costs that are directly related to the research work, 
  • direct costs incurred through the use of research infrastructure linked to the research work and direct costs incurred at Clinical Trial Units or equivalent
  • costs for organising conferences and workshops, national and international cooperation and networking activities
  • costs for PPI (Patient and Public involvement) activities, i.e. costs for involving either the patients, members of their family, carers, the public or the relevant patient organisations during the trial lifecycle, such as hourly compensation for their consulting work, meetings.

Project criteria

The main criteria considered in the evaluation are:

  • Originality, clinical relevance, scientific value and topicality of the study;
  • Feasibility of the project;
  • Documentation of patient and public involvement;

For more information, please contact Anna Lazzarinetti and visit the dedicated website.